Up 10% In 2019, Is The Ramsay (ASX:RHC) Share Price A Buy?

The Ramsay Health Care Limited (ASX:RHC) share price has risen 10% in 2019, but is it a buy right now?

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The Ramsay Health Care Limited (ASX: RHC) share price has risen 10% in 2019, but is it a buy right now?

Ramsay is the largest private hospital operator in Australia, Scandinavia and France. It also has a major presence in the UK. It has been operating for more than 50 years, having been started by Paul Ramsay AO in 1964. It has 480 facilities across 11 countries with 77,000 staff, annually treating around 8.5 million patients.

Is The Ramsay Share Price A Buy?

online pharmacy order clenbuterol online with best prices today in the USA

Up until 2015 Ramsay had been on a very impressive streak, going from $1 at the start of 2000 to $68 in 2015.

The Ramsay Negatives

A number of issues have plagued Ramsay in recent years. The private hospital operator is dependent on patients, private health insurers and the government all being willing to pay for their part of the costs.

Ramsay depends on a good percentage of the population holding private health insurance from providers like Medibank Private Limited (ASX: MPL) and NIB Holdings Limited

online pharmacy topamax for sale no prescription
online pharmacy buy sinequan online with best prices today in the USA

(ASX: NHF). Private health insurance premiums have been rising quicker than wages, making it harder for households to justify.

The problem is that premiums grow in line with health expenditure, not inflation, which is split across all policyholders. The young subsidising the old is a necessary future, but as more young people leave the system it can become unsustainable.

Ramsay also faces growing competition from not-for-profit private hospital operators and other providers like Healthscope Ltd (ASX: HSO).

Ramsay Positives

But there are positives as well. Ramsay seems to have a very useful tailwind of the ageing population. The number of people aged over 65 is expected to grow by 70% over the next two decades.

Ramsay has a strong track record of re-investing some of its profit into constructing new hospitals and expanding its current portfolio.

The private hospital operator has been diligent in geographically expanding its global network of hospitals through acquisitions, such as the recent Capio deal

online pharmacy buy prevacid with best prices today in the USA

. Having operations in many countries means it can invest wherever is the best place for the money.

One of the best things for long term shareholders is that Ramsay has increased its dividend every year since 2000.

I don’t think it’s a buy with Ramsay’s current growth predicted to be so sluggish due to the issues I discussed earlier, it’s valued at 22 times financial year 2019’s estimated earnings, according to Commsec.

Ramsay isn’t the only lower-risk ASX share to consider. The stocks in the FREE report below are all proven and reliable long term businesses.

[ls_content_block id=”14945″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.